Guardian Wealth Management (Illinois)’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$264K Sell
1,392
-210
-13% -$39.5K 0.13% 59
2026
Q1
$316K Sell
1,602
-345
-18% -$66.5K 0.17% 56
2025
Q4
$358K Sell
1,947
-9
-0.5% -$1.58K 0.21% 58
2025
Q3
$300K Buy
1,956
+1
+0.1% +$151 0.18% 56
2025
Q2
$273K Sell
1,955
-25
-1% -$3.5K 0.18% 56
2025
Q1
$291K Sell
1,980
-247
-11% -$35.7K 0.19% 56
2024
Q4
$292K Hold
2,227
0.2% 60
2024
Q3
$347K Buy
2,227
+3
+0.1% +$484 0.24% 57
2024
Q2
$347K Sell
2,224
-13
-0.6% -$1.96K 0.27% 54
2024
Q1
$303K Sell
2,237
-161
-7% -$21.3K 0.23% 55
2023
Q4
$323K Sell
2,398
-163
-6% -$21.2K 0.27% 56
2023
Q3
$347K Sell
2,561
-2,846
-53% -$389K 0.32% 57
2023
Q2
$774K Sell
5,407
-7
-0.1% -$1.03K 0.71% 47
2023
Q1
$752K Sell
5,414
-29
-0.5% -$3.9K 0.72% 48
2022
Q4
$738K Sell
5,443
-65
-1% -$8.15K 0.73% 48
2022
Q3
$604K Buy
5,508
+25
+0.5% +$3.17K 0.68% 51
2022
Q2
$724K Buy
5,483
+20
+0.4% +$2.62K 0.78% 51
2022
Q1
$725K Buy
5,463
+112
+2% +$13.4K 0.72% 53
2021
Q4
$623K Buy
+5,351
New +$630K 0.6% 54

Other funds holding AZN

Guardian Wealth Management (Illinois)'s AZN Position: Q2 2026 in Review

Guardian Wealth Management (Illinois) reduced its AstraZeneca (AZN) stake by 13% in Q2 2026, selling an estimated $39.5K and leaving 1,392 shares worth $264K. The position accounts for 0.13% of the portfolio, ranked #59.

Guardian Wealth Management (Illinois) first reported a position in AZN in Q4 2021 and has held it in 19 quarters since. The position peaked at $774K in Q2 2023. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Guardian Wealth Management (Illinois) held 1,392 shares of AstraZeneca worth $264K as of Q2 2026.
  • Guardian Wealth Management (Illinois) sold 210 AstraZeneca shares in Q2 2026, an estimated $39.5K.
  • AstraZeneca made up 0.13% of Guardian Wealth Management (Illinois)'s portfolio in Q2 2026, its #59 holding.
  • Guardian Wealth Management (Illinois) first reported a position in AstraZeneca in Q4 2021 and has held it in 19 quarters since.
  • Guardian Wealth Management (Illinois)'s AstraZeneca position peaked at $774K in Q2 2023.
  • 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Guardian Wealth Management (Illinois)'s 13F filing for Q2 2026, filed 13 Jul 2026.